The Investigation of the Impact of Atypical Antipsychotics on Brain Functioning in Youths With Conduct Disorder

Trial Profile

The Investigation of the Impact of Atypical Antipsychotics on Brain Functioning in Youths With Conduct Disorder

Discontinued
Phase of Trial: Phase II

Latest Information Update: 01 Feb 2017

At a glance

  • Drugs Aripiprazole (Primary) ; Risperidone (Primary)
  • Indications Conduct disorder
  • Focus Pharmacodynamics
  • Most Recent Events

    • 19 May 2015 Status changed from recruiting to discontinued as per ClinicalTrials.gov record.
    • 20 Jun 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top